Vaughan David Investments LLC IL Reduces Holdings in Colgate-Palmolive (NYSE:CL)

Vaughan David Investments LLC IL trimmed its stake in shares of Colgate-Palmolive (NYSE:CLGet Rating) by 4.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 8,195 shares of the company’s stock after selling 400 shares during the quarter. Vaughan David Investments LLC IL’s holdings in Colgate-Palmolive were worth $699,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Wellington Management Group LLP increased its stake in Colgate-Palmolive by 10.0% in the 3rd quarter. Wellington Management Group LLP now owns 33,925,902 shares of the company’s stock worth $2,564,120,000 after acquiring an additional 3,077,946 shares during the last quarter. Lazard Asset Management LLC increased its stake in Colgate-Palmolive by 359.6% in the 4th quarter. Lazard Asset Management LLC now owns 3,477,341 shares of the company’s stock worth $296,754,000 after acquiring an additional 2,720,790 shares during the last quarter. Allspring Global Investments Holdings LLC bought a new position in Colgate-Palmolive in the 4th quarter worth about $134,062,000. Renaissance Technologies LLC increased its stake in Colgate-Palmolive by 81.4% in the 3rd quarter. Renaissance Technologies LLC now owns 3,408,081 shares of the company’s stock worth $257,583,000 after acquiring an additional 1,529,100 shares during the last quarter. Finally, California Public Employees Retirement System increased its stake in Colgate-Palmolive by 21.4% in the 4th quarter. California Public Employees Retirement System now owns 6,037,320 shares of the company’s stock worth $515,225,000 after acquiring an additional 1,064,282 shares during the last quarter. Institutional investors own 78.12% of the company’s stock.

Several equities analysts have recently commented on the company. Deutsche Bank Aktiengesellschaft reduced their price objective on Colgate-Palmolive from $91.00 to $88.00 in a research report on Monday, May 2nd. Stifel Nicolaus dropped their target price on Colgate-Palmolive from $90.00 to $88.00 in a report on Wednesday, April 13th. Zacks Investment Research cut Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $82.00 target price for the company. in a report on Monday, May 2nd. Sanford C. Bernstein upgraded Colgate-Palmolive from an “underperform” rating to a “market perform” rating and increased their price objective for the stock from $77.00 to $83.00 in a report on Wednesday, February 2nd. Finally, TheStreet upgraded Colgate-Palmolive from a “c+” rating to a “b” rating in a report on Friday, April 29th. Two analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and three have given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $85.56.

Shares of Colgate-Palmolive stock traded up $0.85 during trading hours on Friday, hitting $78.40. The company’s stock had a trading volume of 5,068,563 shares, compared to its average volume of 6,104,116. The business has a 50 day moving average price of $77.28 and a two-hundred day moving average price of $79.12. Colgate-Palmolive has a 12-month low of $72.20 and a 12-month high of $85.61. The company has a market cap of $65.69 billion, a PE ratio of 32.40, a PEG ratio of 5.13 and a beta of 0.56. The company has a debt-to-equity ratio of 10.42, a quick ratio of 0.67 and a current ratio of 1.09.

Colgate-Palmolive (NYSE:CLGet Rating) last announced its quarterly earnings data on Friday, April 29th. The company reported $0.74 EPS for the quarter, meeting the consensus estimate of $0.74. Colgate-Palmolive had a return on equity of 296.77% and a net margin of 11.70%. The business had revenue of $4.40 billion for the quarter, compared to the consensus estimate of $4.40 billion. During the same period in the previous year, the business earned $0.80 earnings per share. The business’s revenue was up 1.3% on a year-over-year basis. As a group, research analysts anticipate that Colgate-Palmolive will post 3.08 earnings per share for the current year.

The company also recently announced a quarterly dividend, which was paid on Friday, May 13th. Stockholders of record on Thursday, April 21st were issued a $0.47 dividend. This represents a $1.88 annualized dividend and a dividend yield of 2.40%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.45. The ex-dividend date was Wednesday, April 20th. Colgate-Palmolive’s payout ratio is 77.69%.

Colgate-Palmolive declared that its Board of Directors has initiated a share repurchase program on Thursday, March 10th that allows the company to buyback $5.00 billion in outstanding shares. This buyback authorization allows the company to repurchase up to 8.1% of its shares through open market purchases. Shares buyback programs are typically an indication that the company’s management believes its stock is undervalued.

In other Colgate-Palmolive news, Director John P. Bilbrey sold 4,917 shares of the business’s stock in a transaction that occurred on Monday, February 14th. The stock was sold at an average price of $78.66, for a total transaction of $386,771.22. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 0.32% of the company’s stock.

Colgate-Palmolive Company Profile (Get Rating)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.